Shark compound proves potential as drug to treat human viruses, says researcher

A compound initially isolated from sharks shows potential as a unique broad-spectrum human antiviral agent. The compound, squalamine, has been in human clinical trials for the treatment of cancer and several eye disorders, and so has a well-known safety profile, suggesting it can be quickly tested as a new class of drugs to treat infections caused by viruses ranging from dengue and yellow fever to hepatitis B, C, and D.

Read the whole article on Science Daily

More from Science Daily